MedTrace Logo

Effectiveness of an HIV Prevention Program That Targets the Inner Workings of High-risk Social Networks

NCT00705705 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 852

Last updated 2011-11-11

No results posted yet for this study

Summary

This study will determine whether an HIV prevention program that targets the inner workings of social networks at high risk for HIV and other sexually transmitted diseases is effective in reducing frequency of high-risk sexual behaviors among network members.

Conditions

  • HIV Infections

Interventions

BEHAVIORAL

Network leader training

Network leaders will receive a nine-session training segment designed to enable them to motivate their peer networks to reduce sexual risk. The sessions will teach the identified leader of each network how to communicate HIV prevention messages to other members of his or her personal social network. Leaders will be asked to share these messages with other members of their groups.

BEHAVIORAL

Standard HIV risk-reduction counseling

Participants will undergo interviews about their friendship groups, sexual behavior, substance abuse, STD treatment history, condom use, and beliefs about HIV/AIDS. Participants will undergo a brief session about HIV/AIDS prevention methods after the first interview.

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Medical College of Wisconsin

    lead OTHER

Principal Investigators

  • Yuri A. Amirkhanian, PhD · Medical College of Wisconsin

  • David W. Seal, PhD · Medical College of Wisconsin

  • Jeffrey A. Kelly, PhD · Medical College of Wisconsin

  • Carol L. Galletly, JD, PhD · Medical College of Wisconsin

  • Laura R. Glasman, PhD · Medical College of Wisconsin

  • Timothy L. McAuliffe, PhD · Medical College of Wisconsin

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-07-31
Primary Completion
2009-03-31
Completion
2009-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00705705 on ClinicalTrials.gov